Anika Therapeutics | ANIK - Lucro Operacional





Lucro Operacional Alterar Data
Abbott USD 1.36B 775M 2026-09
Agenus USD 15.05M 656K 2026-03
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -170.09M 28.83M 2026-06
Enanta Pharmaceuticals USD -23.54M 98.15M 2024-12
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -81.83M 19.48M 2026-09
Integra LifeSciences USD 42.65M 1.36M 2026-09
Intrexon USD -60.84M 26.62M 2024-06
J&J USD 6.47B 1B 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Ligand Pharmaceuticals USD 54.53M 2.1M 2026-09
MacroGenics USD -13.85M 19.59M 2026-06
Merit Medical Systems USD 60.4M 16.25M 2026-06
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 4.72B 2.34B 2026-09
Smith & Nephew USD 505M 65M 2026-06
Stryker USD 1.79B 687M 2026-06
Veracyte USD 18.02M 5.94M 2026-09
Xencor USD -36.6M 41.26M 2026-06
Zimmer Biomet Holdings USD 341.5M 3.2M 2026-09